AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Essity

Regulatory Filings Dec 14, 2023

2912_iss_2023-12-14_64a57f05-8dee-41ad-8d7d-67545310314a.pdf

Regulatory Filings

Open in Viewer

Opens in native device viewer

Press release

Stockholm, December 14, 2023

Strategic review of the Consumer Tissue Private Label Europe business concluded

The Consumer Tissue Private Label Europe business remains a part of the Essity Group and thereby the strategic review of the division, which began on April 26 of this year, is concluded.

Essity continuously evaluates its various businesses to increase long-term value creation. In the strategic review of Consumer Tissue Private Label Europe, it was concluded that the business as a result of the implemented divisionalization, is a competitive and valuecreating part of Essity.

Net sales for the Consumer Tissue Private Label Europe business amounted to approximately SEK 9.8bn in 2022. The business encompasses seven production facilities in Belgium, France, Germany and Italy with approximately 1,900 employees.

NB: This is information that Essity Aktiebolag (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, at 17:30 CET on December 14, 2023.

_____________________________________________________________________________________

________________________________________________________________________________________________ Karl Stoltz, Media Relations Director, +46 709 42 63 38

For additional information, please contact:

Per Lorentz, Vice President Corporate Communications +46 733 13 30 55, [email protected] Sandra Åberg, Vice President Investor Relations, +46 705 64 96 89, [email protected]

About Essity

Essity is a global, leading hygiene and health company. We are dedicated to improving well-being through our products and services. Sales are conducted in approximately 150 countries under the leading global brands TENA and Tork, and other strong brands, such as Actimove, JOBST, Knix, Leukoplast, Libero, Libresse, Lotus, Modibodi, Nosotras, Saba, Tempo, TOM Organic, Vinda and Zewa. Essity has about 48,000 employees. Net sales in 2022 amounted to approximately SEK 156bn (EUR 15bn). The company's headquarters is located in Stockholm, Sweden, and Essity is listed on Nasdaq Stockholm. Essity breaks barriers to well-being and contributes to a healthy, sustainable and circular society. More information at www.essity.com.

Talk to a Data Expert

Have a question? We'll get back to you promptly.